The case was seen as a test of a more aggressive policy by the agency.
Related Posts
Viatris Agrees to Purchase Pacira BioSciences for 1.65 Billion Dollars
Viatris Inc. agreed to purchase Pacira BioSciences Inc. for $36.50 per share in cash on October 8, 2026, establishing an equity valuation of approximately $1.65 billion. The transaction establishes...
Shionogi Buys IntraBio for $2 Billion to Acquire Approved Rare Disease Drug
Shionogi & Co., Ltd. agreed to acquire IntraBio Inc. for $2.0 billion in an all-cash transaction announced on October 5, 2026. The Japanese pharmaceutical company will purchase 100 percent of the...
GE HealthCare Acquires SOFIE Biosciences for $945 Million to Secure Radiopharmaceutical Supply Chain
GE HealthCare announced on October 5, 2026, that it agreed to purchase SOFIE Biosciences from private equity firm Trilantic North America for $945 million in cash. SOFIE Biosciences operates as a...
UK Private Hospital Giant Spire Agrees to £1.03 Billion Buyout Led by Toscafund
Spire Healthcare Group agreed on September 5, 2026, to a £1.03 billion cash takeover by Tulip UK Bidco, an investment consortium led by hedge fund manager Toscafund Asset Management alongside THCP...